Codexis (CDXS) Other Non-Current Assets (2010 - 2026)
Codexis (CDXS) recorded quarterly Other Non-Current Assets of $2.0 million in Q1 2026, up 326.15% quarter-over-quarter from $478000.0 in Q4 2025, and up 30.08% on a YoY basis from $1.6 million in Q1 2025.
Codexis (CDXS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Codexis' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 30.08% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 30.08% YoY), while the FY2025 annual figure was $478000.0, down 69.46% from the prior year.
- Other Non-Current Assets was $2.0 million for Q1 2026 at Codexis, up from $478000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.1 million in Q1 2022 to a low of $478000.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $1.7 million across 5 years, with a median of $1.6 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 252.68% in 2022, then sank 69.46% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $2.0 million in 2022, then slipped by 22.58% to $1.6 million in 2023, then fell by 1.01% to $1.6 million in 2024, then tumbled by 69.46% to $478000.0 in 2025, then jumped by 326.15% to $2.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $2.0 million (Q1 2026), $478000.0 (Q4 2025), and $485000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 2.05 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Mar 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.07 Mn |
| Mar 31, 2022 | 2.09 Mn |
| Dec 31, 2021 | 579,000.00 |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.10 Mn |